These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10223580)

  • 21. Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen: a pilot study in patients with refractory malignancies.
    Pedrazzoli P; Da Prada GA; Giorgiani G; Schiavo R; Zambelli A; Giraldi E; Landonio G; Locatelli F; Siena S; Della Cuna GR
    Cancer; 2002 May; 94(9):2409-15. PubMed ID: 12015766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS; Sen R; Dixit G
    J Assoc Physicians India; 2008 Dec; 56():942-4. PubMed ID: 19322972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.
    Alvarado Ibarra ML; Borbolla Escoboza JR; López-Hernández MA; González-Avante CM; FloresChapa JD; Trueba Christy E; Anaya Cuellar I
    Rev Invest Clin; 1999; 51(2):77-80. PubMed ID: 10410585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe odontogenic infections, part 1: prospective report.
    Flynn TR; Shanti RM; Levi MH; Adamo AK; Kraut RA; Trieger N
    J Oral Maxillofac Surg; 2006 Jul; 64(7):1093-103. PubMed ID: 16781343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors.
    Subirà M; Martino R; Franquet T; Puzo C; Altés A; Sureda A; Brunet S; Sierra J
    Haematologica; 2002 May; 87(5):528-34. PubMed ID: 12010668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial.
    Martino R; Bellido M; Brunet S; Altés A; Sureda A; Guárdia R; Aventín A; Nomdedéu JF; Domingo-Albós A; Sierra J
    Haematologica; 1999 Jun; 84(6):505-10. PubMed ID: 10366793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia.
    Weiss MA; Aliff TB; Tallman MS; Frankel SR; Kalaycio ME; Maslak PG; Jurcic JG; Scheinberg DA; Roma TE
    Cancer; 2002 Aug; 95(3):581-7. PubMed ID: 12209751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The close association between dental and periodontal treatments and oral ulcer course in behcet's disease: a prospective clinical study.
    Karacayli U; Mumcu G; Simsek I; Pay S; Kose O; Erdem H; Direskeneli H; Gunaydin Y; Dinc A
    J Oral Pathol Med; 2009 May; 38(5):410-5. PubMed ID: 19320802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased prevalence of dental caries and poor oral hygiene in juvenile idiopathic arthritis.
    Welbury RR; Thomason JM; Fitzgerald JL; Steen IN; Marshall NJ; Foster HE
    Rheumatology (Oxford); 2003 Dec; 42(12):1445-51. PubMed ID: 12810923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pycnogenol may alleviate adverse effects in oncologic treatment.
    Belcaro G; Cesarone MR; Genovesi D; Ledda A; Vinciguerra G; Ricci A; Pellegrini L; Gizzi G; Ippolito E; Dugall M; Cacchio M; Di Renzo A; Stuard S
    Panminerva Med; 2008 Sep; 50(3):227-34. PubMed ID: 18927527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer.
    Borg C; Ray-Coquard I; Philip I; Clapisson G; Bendriss-Vermare N; Menetrier-Caux C; Sebban C; Biron P; Blay JY
    Cancer; 2004 Dec; 101(11):2675-80. PubMed ID: 15503313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes.
    Pagano L; Mele L; Fianchi L; Melillo L; Martino B; D'Antonio D; Tosti ME; Posteraro B; Sanguinetti M; Trapè G; Equitani F; Carotenuto M; Leone G
    Haematologica; 2002 May; 87(5):535-41. PubMed ID: 12010669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and implementation of a risk assessment tool for chemotherapy-induced neutropenia.
    Donohue R
    Oncol Nurs Forum; 2006 Nov; 33(2):347-52. PubMed ID: 16518450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial.
    Soper JT; Reisinger SA; Ashbury R; Jones E; Clarke-Pearson DL
    Gynecol Oncol; 2004 Oct; 95(1):95-100. PubMed ID: 15385116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Periodontal infection in cancer patients treated with high-dose chemotherapy.
    Raber-Durlacher JE; Epstein JB; Raber J; van Dissel JT; van Winkelhoff AJ; Guiot HF; van der Velden U
    Support Care Cancer; 2002 Sep; 10(6):466-73. PubMed ID: 12353125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Infectious complications in pediatric cancer patients].
    Lehrnbecher T; Laws HJ
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S3-8. PubMed ID: 16288349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.
    Duska LR; Berkowitz R; Matulonis U; Muto M; Goodman A; McIntyre JF; Klein A; Atkinson T; Seiden MV; Campos S
    Gynecol Oncol; 2005 Jan; 96(1):198-203. PubMed ID: 15589601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consolidative abdominopelvic radiotherapy after surgery and carboplatin/paclitaxel chemotherapy for epithelial ovarian cancer.
    Dinniwell R; Lock M; Pintilie M; Fyles A; Laframboise S; Depetrillo D; Levin W; Manchul L; Murphy J; Oza A; Rosen B; Sturgeon J; Milosevic M
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):104-10. PubMed ID: 15850909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.